CT angiography with gadolinium-based contrast media

被引:19
|
作者
Bonvento, Michael J.
Moore, William H.
Button, Terry M.
Weinmann, Hanns-Joachim
Yakupov, Renat
Dilmanian, F. Avraham
机构
[1] SUNY Stony Brook, Univ Hosp, Dept Radiol, Stony Brook, NY 11794 USA
[2] Schering AG, Dept Imaging Technol & Preclin Contrast Media Res, D-1000 Berlin, Germany
[3] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA
[4] Univ Hawaii, Dept Phys, Honolulu, HI 96822 USA
关键词
computed tomography; contrast agent; contrast enhancement; contrast medium; CT angiography; gadolinium contrast agents; iodinated agents; x-ray radiography;
D O I
10.1016/j.acra.2006.03.019
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Rationale and Objectives. To evaluate the potential use of gadolinium (Gd)-based contrast media, especially that of Gadovist, a 1-molar Gd medium, in computed tomography (CT) and compare our findings with standard iodinated contrast media. Material and Methods. Using a live rabbit and an acrylic CT body phantom for comparative CT imaging of Gd- and I-based media. The images were acquired at 80, 100, and 120 kVp, using fixed standard beam filtration. The phantom study used serial dilutions of the Magnevist and Ultravist 300 (2.4-molar 1), whereas the animal study used different volumes of Gadovist, Magnevist (0.5 molar Gd), and Ultravist administered intravenously. Results. At 80 kVp for the same injection volumes of Gadovist and Ultravist, the image contrast enhancement of the aorta with Gadovist was 40% lower than that of Ultravist. In the phantom studies, however, for the same kVp settings the CT image contrast was up to fourfold higher for Gd compared with iodine when comparing the same molar concentrations of the two elements in the solutions. Conclusion. These results indicate a potential of Gd-based media for clinical CT angiography and provide incentive for further investigation of this subject.
引用
收藏
页码:979 / 985
页数:7
相关论文
共 50 条
  • [21] Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media
    Ngoya, P. S.
    Vawda, Z.
    Lotz, J. W.
    SA JOURNAL OF RADIOLOGY, 2013, 17 (03): : 106 - 107
  • [22] Immediate Hypersensitivity Reaction to Gadolinium-based MR Contrast Media
    Jung, Jae-Woo
    Kang, Hye-Ryun
    Kim, Min-Hye
    Lee, Whal
    Min, Kyung-Up
    Han, Moon-Hee
    Cho, Sang-Heon
    RADIOLOGY, 2012, 264 (02) : 414 - 422
  • [23] Anaphylactic risk associated with iodinated and gadolinium-based contrast media
    Bian, Sainan
    Wang, Zixi
    Li, Lisha
    Cui, Le
    Xu, Yingyang
    Guan, Kai
    Zhao, Bin
    Xue, Huadan
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [24] Suggesting gadolinium-based contrast media for CT in azotemic patients is not based on historical, clinical, and experimental data
    Nyman, Ulf
    Elmstahl, Barbara
    Leander, Peter
    RADIOLOGY, 2007, 244 (02) : 622 - U387
  • [25] Consider Risk for Gadolinium Retention in the Brain When Using Gadolinium-based Contrast Media
    Karabulut, Nevzat
    RADIOGRAPHICS, 2016, 36 (02) : 620 - 621
  • [26] ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis
    Thomsen, Henrik S.
    EUROPEAN RADIOLOGY, 2007, 17 (10) : 2692 - 2696
  • [27] Gadolinium-based contrast media may be nephrotoxic even at approved doses
    Henrik S. Thomsen
    European Radiology, 2004, 14 : 1654 - 1656
  • [28] ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis
    Henrik S. Thomsen
    European Radiology, 2007, 17 : 2692 - 2696
  • [29] Intraarterial gadolinium-based contrast material
    Gemery, J
    Reid, S
    Pagan-Marin, H
    RADIOLOGY, 2001, 218 (01) : 304 - 304
  • [30] Gadolinium-based contrast media may be nephrotoxic even at approved doses
    Thomsen, HS
    EUROPEAN RADIOLOGY, 2004, 14 (09) : 1654 - 1656